AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 285: G769-G778, 2003. First published June 19, 2003; doi:10.1152/ajpgi.00009.2003
0193-1857/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/4/G769    most recent
00009.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (36)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Müller, C.
Right arrow Articles by Kiemer, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Müller, C.
Right arrow Articles by Kiemer, A. K.

LIVER AND BILIARY TRACT

{alpha}-Lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway

Christian Müller,1,* Friedrich Dünschede,2,* Elke Koch,1 Angelika M. Vollmar,1 and Alexandra K. Kiemer1

1Department of Pharmacy, Center of Drug Research, University of Munich, 81377 Munich; and 2Department of Surgery, University of Mainz, 55101 Mainz, Germany

Submitted 7 January 2003 ; accepted in final form 11 June 2003

In liver resection and transplantation ischemia-reperfusion injury (IRI) is one of the main causes of organ dys- or nonfunction. The aim of the present study was to determine whether {alpha}-lipoic acid (LA) is able to attenuate IRI. Rat livers were perfused with Krebs-Henseleit buffer with or without LA (±wortmannin), followed by ischemia (1 h, 37°C) and reperfusion (90 min). Efflux of lactate dehydrogenase (LDH) and purine nucleoside phosphorylase (PNP) and hepatic ATP content were determined enzymatically. Activation of NF-{kappa}B and activating protein 1 (AP-1) was examined by EMSA, and protein phosphorylation was examined by Western blot. Caspase-3-like activity served as an indicator for apoptotic processes. Animals treated intravenously with 500 µmol LA were subjected to 90 min of partial no-flow ischemia followed by reperfusion for up to 7 days. Preconditioning with LA significantly reduced LDH and PNP efflux during reperfusion in isolated perfused rat livers. ATP content was significantly increased in LA-treated livers. Postischemic activation of NF-{kappa}B and AP-1 was significantly reduced in LA-pretreated organs. Preconditioning with LA significantly enhanced Akt phosphorylation. It showed neither effect on endothelial nitric oxide synthase nor on Bad phosphorylation. Importantly, simultaneous administration of wortmannin, an inhibitor of the phosphatidylinositol (PI)3-kinase/Akt pathway, blocked the protective effect of LA on IRI, demonstrating a causal relationship between Akt activation and hepatoprotection by LA. Interestingly, despite activation of Akt, LA did not reduce postischemic apoptotic cell death. The efficacy of LA treatment in vivo was shown by reduced GST plasma levels and improved liver histology of animals pretreated with LA. This study shows for the first time that the PI3-kinase/Akt pathway plays a central protective role in IRI of the rat liver and that LA administration attenuates IRI via this pathway.

adenosine 5'-triphosphate; transcription factors; p38 mitogen-activated protein kinase; wortmannin; phosphatidylinositol 3-kinase



Address for reprint requests and other correspondence: A. K. Kiemer, Dept. of Pharmacy, Center of Drug Research, Univ. of Munich, Butenandtstr. 5-13, 81377 Munich, Germany (E-mail: Alexandra.Kiemer{at}cup.uni-muenchen.de).




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
J. R. Klune, T. R. Billiar, and A. Tsung
HMGB1 preconditioning: therapeutic application for a danger signal?
J. Leukoc. Biol., March 1, 2008; 83(3): 558 - 563.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Z. P. Shaik, E. K. Fifer, and G. Nowak
Akt activation improves oxidative phosphorylation in renal proximal tubular cells following nephrotoxicant injury
Am J Physiol Renal Physiol, February 1, 2008; 294(2): F423 - F432.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Z. P. Shaik, E. K. Fifer, and G. Nowak
Protein kinase B/Akt modulates nephrotoxicant-induced necrosis in renal cells
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F292 - F303.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Loverre, P. Ditonno, A. Crovace, L. Gesualdo, E. Ranieri, P. Pontrelli, G. Stallone, B. Infante, A. Schena, S. Di Paolo, et al.
Ischemia-Reperfusion Induces Glomerular and Tubular Activation of Proinflammatory and Antiapoptotic Pathways: Differential Modulation by Rapamycin
J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2675 - 2686.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.